BIOMERICA INC (BMRA)

↓ Download CSV

CIK 0000073290 · Nasdaq · In Vitro & In Vivo Diagnostic Substances

  • Sector Manufacturing
  • Incorporated DE
  • Fiscal year ends May 31

In fiscal 2025, BIOMERICA INC reported revenue of $5.31M, down 1.9% from the prior year. The company ran a net loss, with a net margin of -93.6% and a gross margin of 9.4%. It held $5.95M in total assets against $1.84M in total liabilities.

Key ratios (FY2025)

9.4%
Gross margin
-96.7%
Operating margin
-93.6%
Net margin
-121.1%
Return on equity
-1.9%
Revenue growth (YoY)
Metric (FY)2025202420232022202120202019201820172016
Revenue$5.31M$5.42M$5.34M$18.87M$7.20M$6.69M$5.20M$5.56M$5.79M
Cost of Revenue$4.81M$4.80M$4.89M$15.89M$6.83M$4.95M$3.91M$3.81M$3.77M$3.62M
Gross Profit$498.0K$611.0K$446.0K$2.98M$366.3K$1.74M$1.29M$1.75M$2.02M$1.52M
Operating Income-$5.14M-$6.37M-$7.22M-$4.53M-$7.50M-$2.74M-$2.41M-$1.48M-$954.6K-$827.0K
Net Income-$4.97M-$5.98M-$7.14M-$4.53M-$7.45M-$2.68M-$2.39M-$1.47M-$908.6K-$1.50M
EPS (Diluted)$-2.16$-2.84$-0.50$-0.36$-0.62$-0.26$-0.26$-0.17$-0.11$-0.20
Total Assets$5.95M$9.25M$14.45M$11.37M$11.82M$17.26M$5.25M$5.22M$5.02M$5.73M
Total Liabilities$1.84M$2.66M$2.73M$3.05M$2.59M$3.05M$1.26M
Shareholders' Equity$4.11M$6.59M$11.72M$8.32M$9.23M$14.21M$3.98M$4.33M$4.49M$5.22M
Cash & Equivalents$2.40M$4.17M$9.72M$5.92M$4.20M$8.64M$686.8K$1.20M$1.23M$1.89M
Operating Cash Flow-$3.84M-$5.36M-$5.47M-$479.0K-$5.25M-$4.30M-$2.24M-$1.17M-$722.9K-$208.8K
Capital Expenditures$51.0K$64.0K$57.0K$135.9K$33.6K$101.1K$130.3K$96.1K$91.6K
Shares Outstanding2.55M2.10M16.82M12.87M12.31M11.74M9.68M8.89M8.51M8.17M